BH Kushner

756 total citations
14 papers, 608 citations indexed

About

BH Kushner is a scholar working on Neurology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, BH Kushner has authored 14 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 6 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in BH Kushner's work include Neuroblastoma Research and Treatments (11 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cancer therapeutics and mechanisms (3 papers). BH Kushner is often cited by papers focused on Neuroblastoma Research and Treatments (11 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cancer therapeutics and mechanisms (3 papers). BH Kushner collaborates with scholars based in United States, Hong Kong and Denmark. BH Kushner's co-authors include NK Cheung, Nai‐Kong V. Cheung, Kim Kramer, Lawrence Helson, Karen L. Lindsley, Mary Ann Bonilla, William L. Gerald, S.C. Jhanwar, Nancy S. Rosenfield and Michael P. LaQuaglia and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

BH Kushner

14 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
BH Kushner United States 10 381 267 155 142 109 14 608
T Philip France 14 248 0.7× 206 0.8× 265 1.7× 165 1.2× 101 0.9× 46 692
R. Handgretinger Germany 15 286 0.8× 228 0.9× 222 1.4× 226 1.6× 75 0.7× 33 718
J.P. Vannier France 10 190 0.5× 203 0.8× 185 1.2× 69 0.5× 60 0.6× 26 659
Christine Damm‐Welk Germany 16 132 0.3× 240 0.9× 266 1.7× 160 1.1× 70 0.6× 37 786
MY Mapara Germany 10 177 0.5× 150 0.6× 443 2.9× 161 1.1× 158 1.4× 11 795
Ellen M. Basu United States 15 513 1.3× 310 1.2× 268 1.7× 140 1.0× 175 1.6× 58 772
Moss Tj United States 8 225 0.6× 190 0.7× 290 1.9× 30 0.2× 211 1.9× 12 624
Brian Gadbaw United States 11 309 0.8× 196 0.7× 408 2.6× 280 2.0× 52 0.5× 15 773
Audrey Sylvia Baur Switzerland 12 77 0.2× 249 0.9× 292 1.9× 107 0.8× 51 0.5× 15 716
Sivasish Sindiri United States 13 201 0.5× 230 0.9× 276 1.8× 156 1.1× 120 1.1× 23 661

Countries citing papers authored by BH Kushner

Since Specialization
Citations

This map shows the geographic impact of BH Kushner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by BH Kushner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites BH Kushner more than expected).

Fields of papers citing papers by BH Kushner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by BH Kushner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by BH Kushner. The network helps show where BH Kushner may publish in the future.

Co-authorship network of co-authors of BH Kushner

This figure shows the co-authorship network connecting the top 25 collaborators of BH Kushner. A scholar is included among the top collaborators of BH Kushner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with BH Kushner. BH Kushner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Bear, Misty D., Daniel A. Morgenstern, Karsten Nysom, et al.. (2022). 891P Naxitamab treatment for relapsed or refractory high-risk neuroblastoma: Outcomes from the first prespecified analyses of the Pivotal 201 Trial. Annals of Oncology. 33. S956–S956. 6 indexed citations
2.
3.
Kushner, BH, et al.. (1998). Neuroblastoma and treatment-related myelodysplasia/leukemia: the Memorial Sloan-Kettering experience and a literature review.. Journal of Clinical Oncology. 16(12). 3880–3889. 65 indexed citations
4.
Kushner, BH, Michael P. LaQuaglia, Mary Ann Bonilla, et al.. (1994). Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age.. Journal of Clinical Oncology. 12(12). 2607–2613. 134 indexed citations
5.
Cheung, Nai‐Kong V., BH Kushner, S J Yeh, & Steven M. Larson. (1994). 3F8 monoclonal antibody treatment of patients with stage IV neuroblastoma: a phase II study.. PubMed. 385. 319–28. 39 indexed citations
6.
7.
8.
Kushner, BH & NK Cheung. (1989). GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma. Blood. 73(7). 1936–1941. 5 indexed citations
9.
Kushner, BH & NK Cheung. (1989). GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma. Blood. 73(7). 1936–1941. 144 indexed citations
10.
Kushner, BH & Nai‐Kong V. Cheung. (1988). Neuroblastoma. Pediatric Annals. 17(4). 269–284. 10 indexed citations
11.
12.
Laver, J, BH Kushner, & P. Steinherz. (1987). Juvenile chronic myeloid leukemia: therapeutic insights.. PubMed. 1(10). 730–3. 5 indexed citations
13.
Kushner, BH, et al.. (1987). Myeloablation with diaziquone: in vitro assessment. Blood. 69(6). 1747–1752. 1 indexed citations
14.
Kushner, BH, et al.. (1987). Preclinical assessment of purging with VP-16-213: key role for long- term marrow cultures. Blood. 69(1). 65–71. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T Philip Breakdown of academic impact, for papers by R. Handgretinger Breakdown of academic impact, for papers by J.P. Vannier Breakdown of academic impact, for papers by Christine Damm‐Welk Breakdown of academic impact, for papers by MY Mapara Breakdown of academic impact, for papers by Ellen M. Basu Breakdown of academic impact, for papers by Moss Tj Breakdown of academic impact, for papers by Brian Gadbaw Breakdown of academic impact, for papers by Audrey Sylvia Baur Breakdown of academic impact, for papers by Sivasish Sindiri
Rankless by CCL
2026